Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04686058
Other study ID # FF-2014-203
Secondary ID
Status Completed
Phase Phase 3
First received
Last updated
Start date March 2014
Est. completion date December 2014

Study information

Verified date December 2020
Source Universiti Kebangsaan Malaysia Medical Centre
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This was a prospective, randomized, single-blind controlled clinical trial comparing three sedative regimens for outpatient colonoscopy.


Description:

This was a prospective, randomized, single-blind controlled clinical trial comparing target-controlled infusion (TCI) with propofol and patient-controlled sedation (PCS) with propofol, to conventional combination of midazolam and pethidine, in terms of quality and safety of sedation, and patient recovery during outpatient colonoscopy.


Recruitment information / eligibility

Status Completed
Enrollment 105
Est. completion date December 2014
Est. primary completion date December 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - ASA I or II patients - aged between 18 to 80 years - scheduled for outpatient colonoscopy Exclusion Criteria: - history of or with psychiatric disease - on psychoactive drugs - mentally or physically unable to use the hand-held device for PCS - previous complications from anaesthesia or sedation - potentially difficult airway maintenance - obstructive sleep apnoea - pregnant - with contraindications to the study drugs

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Propofol 10 MG/ML Injection

Midazolam injection

Pethidine Hydrochloride 50 Mg/mL Solution for Injection

Device:
target controlled infusion pump

patient-controlled sedation pump


Locations

Country Name City State
Malaysia Pusat Perubatan Universiti Kebangsaan Malaysia Cheras Kuala Lumpur

Sponsors (1)

Lead Sponsor Collaborator
Universiti Kebangsaan Malaysia Medical Centre

Country where clinical trial is conducted

Malaysia, 

Outcome

Type Measure Description Time frame Safety issue
Other Time taken to onset of sedation Time taken for patient to reach a sedation score of MOAAS 3 or 4 From start of sedation until MOAAS 3 or 4 attained, assessed up to one hour from the point sedation was commenced
Primary Recovery time to Modified Observer's Assessment of Alertness and Sedation Scale (MOAAS) Recovery of patient from sedation when MOAAS 5 is achieved From time of arrival at the recovery area after completion of colonoscopy, until point of discharge from recovery area, assessed up to 2 hours post arrival at recovery
Primary Recovery time to ambulation Recovery of patient from sedation when patient starts ambulating From time of arrival at the recovery area after completion of colonoscopy, until the point patient starts to ambulate, assessed up to 2 hours post arrival at recovery
Primary Recovery time to discharge Recovery of patient from sedation when patient is deemed fit for discharge home From time of arrival at the recovery area after completion of colonoscopy, until the point patient is deemed fit for discharge home, assessed up to 2 hours post arrival at recovery
Primary Endoscopist satisfaction score After completion of colonoscopy, the endoscopist graded on a scale of 1 to 10, ease of the colonoscopy/procedure (1 = very difficult, 10 = very easy), and level of satisfaction (1 = very dissatisfied, 10 = very satisfied) using a 10 cm visual analog scale (VAS). After completion of colonoscopy, the endoscopist graded his satisfaction score from the start of colonoscopy, assessed until 2 hours after completion of colonoscopy
Primary Patient satisfaction score After completion of colonoscopy, the patient graded on a scale of 1 to 10, the level of satisfaction (1 = very dissatisfied, 10 = very satisfied) using a 10 cm visual analog scale (VAS). Patient satisfaction score from start of sedation until point of discharge from recovery assessed until 3 hours from the start of sedation
Primary Patient willingness to repeat the same sedation technique Patient responds yes or no. to willingness of having the same sedation during colonoscopy, in the future From patient arrival to recovery post colonoscopy, area until the point of patient discharge, assessed up to 3 hours after arrival at recovery
Secondary Rescue analgesic drug requirement Requirement for rescue analgesic or sedative in addition to study drugs/sedatives, during the entire duration of colonoscopy From start of sedation, and during the entire duration of colonoscopy, assessed up to 2 hours from the start of sedation
Secondary Total drug consumption Total consumption of all study drugs from the start of sedation, during the entire duration of colonoscopy until completion of colonoscopy Total consumption of all study drugs from the start of sedation, during the entire duration of colonoscopy until completion of colonoscopy, assessed up to 2 hours from the start of sedation
Secondary Ease of colonoscopy score endoscopist graded on a scale of 1 to 10, ease of procedure (1 = very difficult, 10 = very easy) during the entire duration of colonoscopy from the start of colonoscopy, assessed up to 2 hours from the start of colonoscopy
Secondary Recalled events during colonoscopy The number of recalled events during the entire duration of colonoscopy Recalled events retrieved from patient, from arrival to recovery area until point of discharge home, assessed up to 2 hours from arrival at recovery
Secondary Recalled discomfort/ pain during colonoscopy The number of recalled events of discomfor/pain during the entire duration of colonoscopy Recalled events of discomfort/pain retrived from the patient, from arrival to recovery area until point of discharge home, assessed up to 2 hours from arrival at recovery
See also
  Status Clinical Trial Phase
Completed NCT04101097 - Training and Validation of Models of Factors to Predict Inadequate Bowel Preparation Colonoscopy
Completed NCT03247595 - Testing How Well Magnesium Citrate Capsules Work as Preparation for a Colonoscopy N/A
Completed NCT04214301 - An Open-Label Preference Evaluation of BLI800 Phase 4
Withdrawn NCT05754255 - Comparison of High-flow Oxygen With or Without Nasal Positive Airway Pressure (PAP) During Propofol Sedation for Colonoscopy in an Ambulatory Surgical Center N/A
Recruiting NCT02484105 - Comforting Conversation During Colonoscopy: A Trial on Patient Satisfaction Phase 4
Active, not recruiting NCT02264249 - Residual Gastric Volume in Same Day Versus Split Dose and Evening Before Bowel Preparation N/A
Terminated NCT01978509 - The Affect of Low-Volume Bowel Preparation for Hospitalized Patients Colonoscopies N/A
Completed NCT01964417 - The Comparative Study Between Bowel Preparation Method Phase 3
Recruiting NCT01685970 - Comparison of Same-day 2 Sachets Picosulfate Versus High Volume PEG for Afternoon Colonoscopy Phase 3
Completed NCT01518790 - Short Course, Single-dose PEG 3350 for Colonoscopy Prep in Children N/A
Recruiting NCT00748293 - Achievement of Better Examinee Compliance on Colon Cleansing Using Commercialized Low-Residue Diet N/A
Completed NCT00779649 - MoviPrep® Versus HalfLytely®, Low-VolUme PEG Solutions for Colon Cleansing: An InvesTigator-blindEd, Randomized, Trial Phase 4
Completed NCT00671177 - Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique N/A
Completed NCT00380497 - Pico-Salax Versus Poly-Ethylene Glycol for Bowel Cleanout Before Colonoscopy in Children Phase 4
Recruiting NCT00160823 - Impact of a Self-Administered Information Leaflet on Adequacy of Colonic Cleansing for in-Hospital Patients Phase 3
Completed NCT00314418 - Patient Position and Impact on Colonoscopy Time N/A
Completed NCT00390598 - PEG Solution (Laxabon®) 4L Versus Senna Glycoside (Pursennid® Ex-Lax) 36mg and PEG Solution (Laxabon®) 2L for Large Bowel Cleansing Prior to Colonoscopy Phase 2/Phase 3
Completed NCT00427089 - Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening Phase 3
Completed NCT00209573 - A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Elective Colonoscopy Phase 3
Completed NCT05823350 - The Effect of Abdominal Massage on Pain and Distention After Colonoscopy N/A